메뉴 건너뛰기




Volumn 18, Issue 1, 2001, Pages 11-15

Insulin sensitizer combination therapy for type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEGLITINIDE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

EID: 0035145243     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (3)

References (13)
  • 4
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49)
    • (1999) JAMA , vol.281 , pp. 2005
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3
  • 5
    • 0005169502 scopus 로고    scopus 로고
    • United Kingdom Prospective study 24: A 6-year randomized controlled trial comparing sulfonylurea insulin metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy
    • (1998) Ann Intern Med , vol.128 , pp. 165
  • 9
    • 0027399661 scopus 로고
    • Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups
    • (1993) Diabetes Care , vol.16 , pp. 621
    • Nagi, D.K.1    Yudkin, J.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.